|
|
Year : 1996 | Volume
: 17
| Issue : 2 | Page : 79-84 |
|
TAL-1 deletion in T cell acute lymphoblastic leukemia implications in the detection of minimal residual disease.
K Nirmala, K Kalaichelvi, KR Rajalakshmi, SG Raman, Dongen JJM Van, V Shantha, T Rajkumar
Cancer Institute, Madras, India
Correspondence Address:
K Nirmala Cancer Institute, Madras, India
 Source of Support: None, Conflict of Interest: None  | Check |

|
|
Conclusion: The greatest utility of the TAL-1 deletion is in the detection of MRD by PCR in T-ALL. The association with clinical and CD3 immunophenotype warrants studies in greater number of patients. |
|
|
|
[PDF Not available]* |
|
 |
|